Wei Lin - Jul 15, 2021 Form 3 Insider Report for Erasca, Inc. (ERAS)

Role
Chief Medical Officer
Signature
/s/ Ebun S. Garner, Attorney-in-Fact
Stock symbol
ERAS
Transactions as of
Jul 15, 2021
Transactions value $
$0
Form type
3
Date filed
7/15/2021, 09:37 PM
Next filing
Feb 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ERAS Common Stock 313K Jul 15, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ERAS Stock Option (Right to Buy) Jul 15, 2021 Common Stock 833K $3.36 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 312,500 shares subject to repurchase by us, which are subject to vesting.
F2 25% of the shares subject to the options vest on January 11, 2022, the one-year anniversary of the vesting commencement date, and 1/48th of the shares subject to the option vest monthly thereafter.

Remarks:

Exhibit 24 - Power of Attorney